Business News WHO backs antibody treatment for high-risk Covid patients WHO says critically ill Covid patients unable to mount an adequate immune response can take synthetic antibody treatment Regeneron Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window) Related UAE stock market regulator, Dubai World Trade Centre Authority agree to support crypto … First Yas Creative Hub units set for handover by year-end